Member Info for EarlofAim

Hopefully sellers done,

could also get boots for physical retail. I won't rule out Selfridges and Harrods.
with Mr Beckham this can go very very far.
GLA and Dyor

Gultekin

you hit the nail on the head. sports injuries and beauty product both are worth hundred of million pounds if it can be sold in huge numbers.
Future looks very good for the company
IMO

OBSTANDO

stay focused on CBX CellularGoods. and watch how hard this bounce on news

huge RNS today, can't believe I can buy at this level, huge. I seen company gets noticed one the following day of the rns.
should rise tomorrow

that team on Cbx worth £100M+ alone on their capabilities.
any wonder ipo day sp reached 27p with a single product of sale.
main assets of the company is the team members.
this company will become very successful and the RNS WILL READ "we had smashed our 3 year expectations, and the Company has bright future".

just matter of time,

Alexia BlakeHead of Research & Product Development

Alexia Blake is a pioneer in the North American cannabis industry with a proven track record of developing efficacious products based on science and clinical evidence. Leveraging her food industry experience, she began her career in the cannabis space at MedReleaf Corp., one of the first Canadian producers of medical cannabis to receive a license from Health Canada. While at MedReleaf, the company became one of the largest global producers of legal cannabis and was eventually acquired in 2018 by Aurora for $2.5 billion.

Alexia led the development of Aurora’s global CBD portfolio for the health and wellness market before joining LAVVAN Inc., a leading company focused on commercializing high-quality cannabinoid ingredients produced using biosynthesis for the health, beauty, food, beverage and pharmaceutical markets.

Sara HemmingCreative Director

Sara's previous employment includes Global Visual Director of Stella McCartney and Creative Director and partner of DJA, working with clients such as Prada, Dior, Rag & Bone, and Another Magazine.

In 2016 she started her own studio, with ongoing brand collaborations in the luxury and lifestyle realms including Joseph, Jimmy Choo, Barbara Sturm and David Beckham.

Peter WallNon-Executive Chairman

Peter is an entrepreneur based in Ottawa, Canada. Peter is the CEO of Argo Blockchain plc, the LSE’s first crypto asset company listing. At Argo, he has overseen the company’s rapid growth from a £20M market cap to exceed £1billion at one stage.

Peter has a history of ‘firsts’ across various industries, including founding Weave Technologies, an infrastructure company focused on high-quality genetics and seeds, co-founding Hubud, Bali’s first co-working space, and launching Wildflowers, one of the first meditation apps in the Apple app store. He has been featured in Virgin Entrepreneur and appeared on CNBC and Bloomberg.

Simon WaltersFD

Simon qualified as a chartered accountant and worked in corporate finance at Stoy Hayward (now BDO). He then joined Fuller Peiser as Finance Partner, before becoming FD of the Molyneux property group with its controlling interest in a listed PLC. Simon was then FD at Shani, a manufacturing company listed on the London Stock Exchange’s main market, and subsequently FD at privately-held investment fund Wood Hall Securities. Simon has also been a director of AIM-quoted Bilston & Battersea Enamels plc; FD of the Fish! chain of restaurants bought out of receivership; a director of NetFM, an internet radio station; FD of AIM-quoted AFC Energy plc and Neville Porter plc; FD of main market-listed OTAQ plc; and provided FD services to a portfolio of companies through Headline FD.

Eric ChangCOO

Eric is an experienced pharmaceutical and healthcare executive with over a decade of operational management and business development experience. Beginning his career at Vancouver Coastal Health followed by a management role at Health Canada. Most recently, Eric led the Clinical Services and business development teams in Western Canada for AmerisourceBergen and Shoppers Drug Mart Specialty Health Network.

CEO

Alexis AbrahamCEO

Alexis has worked for two decades in strategic branding, communications, and internet-enabled businesses. He founded a pair of consumer-tech solutions: a specialist stationery platform in the UK, and theatre ticketing SaaS in South Africa. Prior to this at design agency Pentagram he worked with the Savoy Hotel, Dorchester Collection, Mothercare, and software pioneer Thoughtworks amongst other global clients.

At ICM in London he led a new team in their ‘talent branding’ programme working with international icons like Claudia Schiffer, Natalia Vodianova, and Daniel Craig to explore and leverage their potential beyond the screen and stage.

has anyone seen the team of CBX?

2 years cellular goods been working on this project, how many hours involved trying to find the best formulation to bring Serum as a Biosynthetic Cannabinoids cream.

I'm confident by September this will be significantly higher than today's SP.

For a company to be valued, it doesn't neeed to sell anything because Research and development finding could be worth a huge valuation.

lots of companies not selling however do have lots of knowledge and ability to convert research into revenues

Cellular Goods is one of them, September is product launch in the meantime lots of other valuable news to come.

facts...for September launch

the launch of product is real, The product is real, the team is real, Biosynthetic Cannabinoids is real, Research and development been since last 2 years, the only unreal here is Share price and some calling this pipe dream.

these facts were known before the launch yet Sp rose to 27P

CEO needs to calm the market with positive Rns.

next is the date of the product launch.
its not easy launching a global product with David Beckham name associated with the company.

shareholders looks impressive and I Nigel Wray who is worh £315M, holds 11% of hawkwing.

plus other impressive holders, SPAC is hot in the UK, Europe and USA for companies to list easier than the standard route to market.

really good information about HNG and the shareholders on twitter.

osbando

this one for you

first pure-play biosynthetic cannabinoids consumer products firm to list on the LSE.

and Zoe is only another CBD this is different,

zoetic don't make Serum nor sports related injuries prodi.

Stop saying my research in incorrect. I what's incorrect is your selfish opinion.
Deramping while Sky news is very bullish on the CBX IPO